Patents by Inventor Gerard BOSS

Gerard BOSS has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210213031
    Abstract: Methods and compositions for treating cyanide, sulfide, or methane-thiol exposure in a subject. The compositions may include one or more cobinamide compounds, such as an amino-tetrazole-cobinamide and/or a di-(amino-tetrazole)-cobinamide.
    Type: Application
    Filed: June 4, 2019
    Publication date: July 15, 2021
    Applicants: The Regents of the University of California, The Regents of the university of Colorado
    Inventors: Gerard Boss, Adriano Chan, Matthew Brenner, Sari Brenner Mahon, Vikhyat Bebarta
  • Patent number: 10272096
    Abstract: The invention generally relates to methods for treating and/or reducing the severity of a wound in a subject. Provided are wound therapies combining low level light therapy (LLLT) and a nitric oxide (NO) donor to treat and/or reduce the severity of the wound. The LLLT and NO donor may be administered concurrently or sequentially. Also provided are wound treatment systems and kits including a light source and a NO donor, which are administered to a wounded subject. Further provided are pharmaceutical compositions that comprise a NO donor and are formulated to be administered in conjunction with LLLT.
    Type: Grant
    Filed: June 6, 2014
    Date of Patent: April 30, 2019
    Inventors: Michael W. Berns, Ryan M. Spitler, Gerard Boss
  • Publication number: 20160113941
    Abstract: The invention generally relates to methods for treating and/or reducing the severity of a wound in a subject. Provided are wound therapies combining low level light therapy (LLLT) and a nitric oxide (NO) donor to treat and/or reduce the severity of the wound. The LLLT and NO donor may be administered concurrently or sequentially. Also provided are wound treatment systems and kits including a light source and a NO donor, which are administered to a wounded subject. Further provided are pharmaceutical compositions that comprise a NO donor and are formulated to be administered in conjunction with LLLT.
    Type: Application
    Filed: June 6, 2014
    Publication date: April 28, 2016
    Applicant: The Regents of the University of California
    Inventors: Michael W. BERNS, Ryan M. SPITLER, Gerard BOSS